New Cannabis Facility Means More Cultivation

" FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year. This year we will seek …

New Cannabis Facility 400 million grams of annual cannabis production

" FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year. This year we will seek a listing on a major U.S. exchange and we also have an interest to acquire a synthetic cannabinoid company that is advancing research and development of FDA approved application at FSD Pharma. We are all inspired by science and driven by a scientific innovation." -Co-Chairman & CEO Raza Bokhari.

Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

For more information on FSD Pharma (HUGE:CSE) please fill out the form below.

No items found.

You might also like

Selkirk Copper Mines Advances Yukon Restart with First Nation Partnership
Metals & Mining
March 6, 2026

Selkirk Copper Mines Advances Yukon Restart with First Nation Partnership

This is some text inside of a div block.
CEO Clips - Selkirk Copper Mines Targets 2028 Restart of Former Yukon Producer
Metals & Mining
March 6, 2026

CEO Clips - Selkirk Copper Mines Targets 2028 Restart of Former Yukon Producer

This is some text inside of a div block.
CEO Clips - Cannara Biotech Expands Cannabis Production with Mega Facilities
Cannabis
March 5, 2026

CEO Clips - Cannara Biotech Expands Cannabis Production with Mega Facilities

Cannara Biotech is building its strategy around those factors through two large cultivation facilities designed specifically for cannabis production.

This is some text inside of a div block.
Subscribe and receive the investor Info